Research and Development Department

Since its establishment Sicor Biotech UAB has always had a Research and Development (R&D) department. In twenty years extensive experience has been gathered in the development of recombinant proteins manufacturing technologies and their application for the needs of the biopharmaceutical industry.

Our R&D specialists are knowledgeable in the fields of biochemistry, biology, microbiology, genetics, chemistry, bioengineering, and natural science. This department has a large lab complex where biosynthesis processes of bacterial and mammalian cell cultures, and protein purification technologies are researched and related analytical methods are developed.

The key R&D objectives cover a wide range of scientific and applied solutions: here we develop efficient technologies for biosynthesis of genetically modified micro organisms and purification of proteins, define these processes to their smallest details, develop analytical processes enabling the analysis of the protein structure of target recombinant therapeutic proteins and their qualitative and quantitative properties. The R&D of Sicor Biotech also develops biopharmaceutical formulations ensuring a long-term stability of proteins.

In 2004 the research and applied works performed at Sicor Biotech were recognised by awarding V.A. Bumelis, Prof., J.H. Pesliakas, PhD and our former employees V. Naktinis, PhD and M. Mauricas, PhD the National Science Prize – the highest scientific award in Lithuania.